Ginkgo biloba in Down Syndrome

Phytomedicine

Volumn 11, Issue 6, 2004, Pages 469-

  Donfrancesco, R ^a   Dell'uomo, A ^a  

^a La Scarpetta Hospital ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; DONEPEZIL; GINKGO BILOBA EXTRACT; GK 501;

ADOLESCENT; CASE REPORT; CHILD; CHOLINERGIC SYSTEM; DOWN SYNDROME; DRUG EFFICACY; EDITORIAL; HUMAN; MALE; PRIORITY JOURNAL; RATING SCALE; SCORING SYSTEM; TRISOMY 21;

GINKGO BILOBA;

EID: 4944220507     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2004.03.002     Document Type: Editorial

References (3)

1. DeFeudis, F.V., Drieu, K., 2000. Ginkgo biloba extract (EGb 761) and CNS functions: basic studies and clinical applications. Curr. Drug Targets 1 (1), 25-58.
2. Kishnani, P.S., Sullivan, J.A., Walter, B.K., Spiridigliozzi, G.A., Doraiswamy, P.M., Krishnan, K.R., 1999. Cholinergic therapy for Down's Syndrome. Lancet 2, 353 (9158), 1064-1065.
3. Wettstein, A., 2000. Cholinesterase inhibitors and Ginkgo extracts-are they comparable in the treatment of dementia? Comparison of published placebo-controlled efficacy studies of at least six months' duration. Phytomedicine 6 (6), 393-401.